IN8bio Inc
INAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.09M
Close$
$5.56
275.5% upside
Current Fair Value
275.5% upsideUndervalued by 275.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.09 Million |
|---|---|
| Enterprise Value | $-5,501,500.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.44 |
| Beta | 0.19 |
| Outstanding Shares | 4,374,328 |
Return
| Return on Equity | -83.32% |
|---|---|
| Return on Assets | -72.26% |
| Return on Invested Capital | -77.83% |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | 3.98 |
| Price to Sales | - |
| Price to Book Ratio | 0.3 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.29 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.43 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-0.59
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 85.79%▲ 12.00% |
|---|---|
| Total Invested | $5.55M▼ 25.45% |
| Investors Holding | 19▼ 3.00% |
ESG Score
No data
About IN8bio Inc
7 employees
CEO: William Ho